Endovascular Engineering, Inc. ("E2"), is a mission driven, venture-backed company focusing on the development and deployment of groundbreaking clot removal technologies that target venous thromboembolism.
| Website | http://www.e2helo.com |
| Employees | 39 (2 on RocketReach) |
| Address | 3925 Bohannon Dr STE 300, Menlo Park, California 94025, US |
| Industry | Medical Equipment Manufacturing |
| Keywords | Endovascular Devices, Venous Thromboembolism, Endovascular Technology, Thrombectomy, Blood Clot Treatment, Deep Vein Thrombosis, Pulmonary Embolism, Vascular Intervention, Catheter Based Therapy, Interventional Cardiology, Medical Devices, Peripheral Vascular Disease, Breakthrough Technology, Medical Technology, Healthcare Technology |
Looking for a particular Endovascular Engineering employee's phone or email?
Endovascular Engineering Questions
Dan Rose is the CEO of Endovascular Engineering.
2 people are employed at Endovascular Engineering.
Endovascular Engineering is based in Menlo Park, California.
Top Endovascular Engineering Employees
-
Dan Rose
Chief Executive Officer at Endovascular Engineering
Lausanne, VD, CH55+ -
22
Related Companies
G2Crowd Trusted
300K+
Plugin Users
